A tender offer for all outstanding shares of Alere's Series B convertible perpetual preferred stock has been launched by Abbott at $402 per share, along with accrued and unpaid dividends. The offer, which comes as part of Abbott's $5.3 billion acquisition of Alere, will expire at midnight Aug. 11.
Tender offer for Alere shares initiated by Abbott
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.